The anti-inflammatory effect of corticosteroid therapy is mediated by the release of anti-inflammatory mediators such as IL-10 and by blocking the release of pro-inflammatory/inflammatory mediators including IL-6 and TNF-α, supporting studies in COVID-19 patients that showed decreased values of CRP and IL-6. The gene discussed is CRP; the disease is COVID-19.